Making Sense of Reflux Testing (AMW2023)

Making Sense of Reflux Testing (AMW2023)

PROGRAM DESCRIPTION: Anaphylaxis is an acute, potentially life-threatening systemic allergic reaction that may have a wide range of clinical manifestations. The lifetime prevalence of anaphylaxis has been estimated at 1.6% to 5.1%. Medications and stinging insects are the leading triggers in adults, with foods and stinging insects the most frequently implicated triggers in children and adolescents. Food allergy impacts 8% to 11% of children and adults in the United States. IgE binding and cross-linking of the high affinity IgE receptor (Fc RI) on the surface of mast cells and basophils is an importantmechanism in many cases of anaphylaxis. Anaphylaxis involves additional cell types that may include neutrophils, monocytes, macrophages, and platelets.Epinephrine administered intramuscularly into the anterolateral thigh is the first-line treatment for anaphylaxis. Epinephrine is the cornerstone of anaphylaxis management but continues to be underutilized. Antihistamines and/or glucocorticoids are not reliable interventions to prevent biphasic anaphylaxis.This session will work through case-based scenarios of allergy emergencies and anaphylaxis. Elements of the patient s history and physical exam findings will be used to determine the diagnosis. Treatment strategies will be discussed, with particular attention to allergy emergencies encountered in the clinical setting.The presenters will lead the participants through the Anaphylaxis A 2020 Practice Parameter Update, Systematic Review, and Grading ofRecommendations, Assessment, Development and Evaluation (GRADE) analysis by working through several real world scenarios.We will work through a case that presents as an episode of anaphylaxis triggered from allergy testing. It is important that otolaryngologists offering allergy services be competent in the management of anaphylaxis.OUTCOME OBJECTIVE 1: Recognize the signs and symptoms of anaphylaxisOUTCOME OBJECTIVE 2: Acknowledge that epinephrine is the first line treatment for anaphylaxisOUTCOME OBJECTIVE 3: Demonstrate competence in treating anaphylaxisBACKGROUND STATEMENT: Management of anaphylaxis and other allergy emergencies has been identified in a comprehensive gap analysis conducted by the AAO-HNSF Education Committees. Many members may not be aware that there has been a recent practice parameter update to anaphylaxis published.

  • Provider:American Academy of Otolaryngology – Head & Neck Surgery Foundation
  • Activity Link: http://media.mycrowdwisdom.com.s3.amazonaws.com/aao-hnsf/2023_Annual_Meeting_Webcasts/23AMW2409601.mp4
  • Start Date: 2023-10-01 05:00:00
  • End Date: 2023-10-01 05:00:00
  • Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
  • MOC Credit Details: ABOHNS - 1.0 Point; Credit Type(s): Self-Assessment (ABOHNS)
  • Commercial Support: No
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: Yes
  • Measured Outcome: Community/Population Health, Learner Competence, Learner Knowledge, Learner Performance, Patient Health
  • Provider Ship: Directly Provided
  • Registration: Open to all
  • Specialty: Allergy
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.